TP63 and anaplastic large cell lymphoma: The urgent need for better understanding of the disease pathobiology and for improved therapeutic strategies in TP63-rearranged ALCL is however, hampered by the lack of ex vivo model systems for mechanistic studies and evaluation of drug candidates.